(Q41120824)

27 September 2017

title

Doxorubicin sensitizes human bladder carcinoma cells to Fas-mediated cytotoxicity (English)

1 reference

27 September 2017

0 references

1 reference

1 reference

Mizutani Y

1 reference

27 September 2017

Okada Y

1 reference

27 September 2017

Yoshida O

1 reference

27 September 2017

Fukumoto M

1 reference

27 September 2017

Bonavida B

1 reference

27 September 2017

language of work or name

English

0 references

publication date

1 March 1997

1 reference

27 September 2017

1 reference

27 September 2017

1 reference

27 September 2017

1 reference

27 September 2017

page(s)

1180-1189

1 reference

Hierarchy of in vitro sensitivity and resistance of tumor cells to cytotoxic effector cells, cytokines, drugs and toxins

27 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819970315%2979%3A6%3C1180%3A%3AAID-CNCR17%3E3.0.CO%3B2-W

Evaluating and designing cancer chemotherapy treatment using mathematical models.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819970315%2979%3A6%3C1180%3A%3AAID-CNCR17%3E3.0.CO%3B2-W

Overcoming cis-diamminedichloroplatinum (II) resistance of human ovarian tumor cells by combination treatment with cis-diamminedichloroplatinum (II) and tumor necrosis factor-alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819970315%2979%3A6%3C1180%3A%3AAID-CNCR17%3E3.0.CO%3B2-W

Fas and perforin pathways as major mechanisms of T cell-mediated cytotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819970315%2979%3A6%3C1180%3A%3AAID-CNCR17%3E3.0.CO%3B2-W

Fas-mediated cytotoxicity by freshly isolated natural killer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819970315%2979%3A6%3C1180%3A%3AAID-CNCR17%3E3.0.CO%3B2-W

The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819970315%2979%3A6%3C1180%3A%3AAID-CNCR17%3E3.0.CO%3B2-W

Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819970315%2979%3A6%3C1180%3A%3AAID-CNCR17%3E3.0.CO%3B2-W

The TNF receptor superfamily of cellular and viral proteins: activation, costimulation, and death

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819970315%2979%3A6%3C1180%3A%3AAID-CNCR17%3E3.0.CO%3B2-W

Lethal effect of the anti-Fas antibody in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819970315%2979%3A6%3C1180%3A%3AAID-CNCR17%3E3.0.CO%3B2-W

Monoclonal antibody-mediated tumor regression by induction of apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819970315%2979%3A6%3C1180%3A%3AAID-CNCR17%3E3.0.CO%3B2-W

Overcoming tumor necrosis factor-alpha resistance of human renal and ovarian carcinoma cells by combination treatment with buthionine sulfoximine and tumor necrosis factor-alpha. Role of tumor necrosis factor-alpha mRNA down-regulation in tumor cell

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819970315%2979%3A6%3C1180%3A%3AAID-CNCR17%3E3.0.CO%3B2-W

Enhancement of sensitivity of urinary bladder tumor cells to cisplatin by c-myc antisense oligonucleotide

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819970315%2979%3A6%3C1180%3A%3AAID-CNCR17%3E3.0.CO%3B2-W

A Method for Testing for Synergy with Any Number of Agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819970315%2979%3A6%3C1180%3A%3AAID-CNCR17%3E3.0.CO%3B2-W

Relationship of inherent resistance to doxorubicin, proliferative activity and expression of P-glycoprotein 170, and glutathione S-transferase-pi in human lung tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819970315%2979%3A6%3C1180%3A%3AAID-CNCR17%3E3.0.CO%3B2-W

Multidrug resistance (mdr) genes in human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819970315%2979%3A6%3C1180%3A%3AAID-CNCR17%3E3.0.CO%3B2-W

Protection from Fas-mediated apoptosis by a soluble form of the Fas molecule

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819970315%2979%3A6%3C1180%3A%3AAID-CNCR17%3E3.0.CO%3B2-W

bcl-2 inhibits multiple forms of apoptosis but not negative selection in thymocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819970315%2979%3A6%3C1180%3A%3AAID-CNCR17%3E3.0.CO%3B2-W

FAP-1: a protein tyrosine phosphatase that associates with Fas

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819970315%2979%3A6%3C1180%3A%3AAID-CNCR17%3E3.0.CO%3B2-W

Apoptosis. Its significance in cancer and cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819970315%2979%3A6%3C1180%3A%3AAID-CNCR17%3E3.0.CO%3B2-W

Apoptosis of lung cancer cells caused by some anti-cancer agents (MMC, CPT-11, ADM) is inhibited by bcl-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819970315%2979%3A6%3C1180%3A%3AAID-CNCR17%3E3.0.CO%3B2-W

Effects of bacillus calmette-guerin on cytotoxic activities of peripheral blood lymphocytes against human T24 lined and freshly isolated autologous urinary bladder transitional carcinoma cells in patients with urinary bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819970315%2979%3A6%3C1180%3A%3AAID-CNCR17%3E3.0.CO%3B2-W

Serum granulocyte colony-stimulating factor levels in patients with urinary bladder tumour and various urological malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819970315%2979%3A6%3C1180%3A%3AAID-CNCR17%3E3.0.CO%3B2-W

The streptococcal preparation OK-432 specifically augments the susceptibility of human urinary bladder tumor cells to autologous peripheral blood lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819970315%2979%3A6%3C1180%3A%3AAID-CNCR17%3E3.0.CO%3B2-W

Determination of the concentration of adriamycin and its metabolites in the serum and tissues of Ehrlich carcinoma-bearing mice by high-performance liquid chromatography

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819970315%2979%3A6%3C1180%3A%3AAID-CNCR17%3E3.0.CO%3B2-W

Effect of glutathione and its related enzymes on chemosensitivity of renal cell carcinoma and bladder carcinoma cell lines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819970315%2979%3A6%3C1180%3A%3AAID-CNCR17%3E3.0.CO%3B2-W

10.1002/(SICI)1097-0142(19970315)79:6<1180::AID-CNCR17>3.0.CO;2-W

21 January 2018

Identifiers

DOI

1 reference

27 September 2017

1 reference